Patent · US Active

CD37-binding molecules and immunoconjugates thereof

US8765917B2 · kind B2 · utility

14Cited by

5References

26Claims

0Family size

Assignee

IMMUNOGEN, INC. · US

Inventors

Jutta Deckert · Lexington, US
Peter U. Park · Lexington, US
Daniel Tavares · Natick, US
Lingyun Rui · Weston, US

Key dates

Filing date	Mar 11, 2011
Grant date	Jul 1, 2014
Priority date	—
Expiry date	Nov 23, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70596
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to CD37 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.